|
|
|
| home > epc > winter 2002 > the growing importance of cold chain distribution in the pharmaceutical and biotechnology industries |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
This article aims to give an overview of the direction in which the distribution industry is developing and the options available for companies requiring improved performance from their temperature controlled packaging (TCPs) and also companies requiring this type of specialised packaging in relation to their new products.
The Future for the Industry is in Temperature Sensitive Products
Recently, Lehman Brothers research reported that four out of the six big US drug groups are heading for zero growth. This change from the steady 10 per cent growth seen just a few years ago is partially due to the number of drugs coming off patent and not being replaced by new patented drugs. The drugs coming off patent are usually faced with a number of generic 'substitutes' at reduced prices. Many pharma companies such as Novartis - who are faced with generic copies of their own products in the marketplace - are continuing to invest in these generic manufacturers to hedge their position.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
DIA Annual EuroMeeting
26-28 March 2012, Copenhagen, Denmark
The EuroMeeting attracts more than 3,000 professionals from over 50 countries. It brings together professionals from the biopharmaceutical industry, contract service organisations, clinical research, regulatory agencies, health ministries, patients’ organisations and universities. This convergence affords attendees the opportunity to network with professional colleagues from around the world.
More info >> |
|
 |
News and Press Releases |
 |
Record sales of new de-blistering and leak testing equipment at packaging machinery manufacturer, Sepha Ltd
The packaging machinery manufacturer, Sepha Ltd, has reported record sales of its recently extended range of non-destructive leak testing equipment for the world's pharmaceutical packaging industry. With demand up across all major markets, the company says the increase will fund future R&D and enable it to bring forward future innovations aimed at reducing costs and driving quality for pharmaceutical manufacturers and contract packers.
More info >> |
|
|
